Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8677 | 1160 | 36.9 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
574 | 13610 | STRUMA OVARII//OVARIAN CANCER//OVARIAN NEOPLASMS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ARID1A | Author keyword | 81 | 79% | 4% | 52 |
2 | CLEAR CELL CARCINOMA | Author keyword | 39 | 30% | 10% | 111 |
3 | OVARIAN CLEAR CELL CARCINOMA | Author keyword | 29 | 55% | 3% | 36 |
4 | LOW GRADE SEROUS CARCINOMA | Author keyword | 20 | 66% | 2% | 19 |
5 | BAF250A | Author keyword | 19 | 76% | 1% | 13 |
6 | ATYPICAL ENDOMETRIOSIS | Author keyword | 19 | 71% | 1% | 15 |
7 | OVARIAN CLEAR CELL ADENOCARCINOMA | Author keyword | 14 | 64% | 1% | 14 |
8 | CLEAR CELL ADENOCARCINOMA | Author keyword | 10 | 24% | 3% | 35 |
9 | CLEAR CELL ADENOFIBROMA | Author keyword | 8 | 75% | 1% | 6 |
10 | LOW GRADE SEROUS | Author keyword | 8 | 100% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARID1A | 81 | 79% | 4% | 52 | Search ARID1A | Search ARID1A |
2 | CLEAR CELL CARCINOMA | 39 | 30% | 10% | 111 | Search CLEAR+CELL+CARCINOMA | Search CLEAR+CELL+CARCINOMA |
3 | OVARIAN CLEAR CELL CARCINOMA | 29 | 55% | 3% | 36 | Search OVARIAN+CLEAR+CELL+CARCINOMA | Search OVARIAN+CLEAR+CELL+CARCINOMA |
4 | LOW GRADE SEROUS CARCINOMA | 20 | 66% | 2% | 19 | Search LOW+GRADE+SEROUS+CARCINOMA | Search LOW+GRADE+SEROUS+CARCINOMA |
5 | BAF250A | 19 | 76% | 1% | 13 | Search BAF250A | Search BAF250A |
6 | ATYPICAL ENDOMETRIOSIS | 19 | 71% | 1% | 15 | Search ATYPICAL+ENDOMETRIOSIS | Search ATYPICAL+ENDOMETRIOSIS |
7 | OVARIAN CLEAR CELL ADENOCARCINOMA | 14 | 64% | 1% | 14 | Search OVARIAN+CLEAR+CELL+ADENOCARCINOMA | Search OVARIAN+CLEAR+CELL+ADENOCARCINOMA |
8 | CLEAR CELL ADENOCARCINOMA | 10 | 24% | 3% | 35 | Search CLEAR+CELL+ADENOCARCINOMA | Search CLEAR+CELL+ADENOCARCINOMA |
9 | CLEAR CELL ADENOFIBROMA | 8 | 75% | 1% | 6 | Search CLEAR+CELL+ADENOFIBROMA | Search CLEAR+CELL+ADENOFIBROMA |
10 | LOW GRADE SEROUS | 8 | 100% | 0% | 5 | Search LOW+GRADE+SEROUS | Search LOW+GRADE+SEROUS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ATYPICAL ENDOMETRIOSIS | 95 | 84% | 4% | 52 |
2 | DISTINCT HISTOLOGIC TYPE | 76 | 67% | 6% | 68 |
3 | 2 TIER SYSTEM | 66 | 83% | 3% | 38 |
4 | CLEAR CELL CARCINOMA | 48 | 28% | 13% | 145 |
5 | GRADE SEROUS CARCINOMA | 38 | 51% | 5% | 54 |
6 | REMODELING GENE ARID1A | 26 | 64% | 2% | 25 |
7 | HOSPITAL DISCHARGE DIAGNOSIS | 25 | 60% | 2% | 27 |
8 | BORDERLINE TUMORS | 20 | 25% | 6% | 71 |
9 | ARID1A | 18 | 45% | 3% | 30 |
10 | UNIVERSAL GRADING SYSTEM | 11 | 60% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pathobiology of ovarian carcinomas | 2015 | 3 | 21 | 57% |
The relation between endometriosis and ovarian cancer - a review | 2014 | 18 | 59 | 73% |
Updates and emerging therapies for rare epithelial ovarian cancers: One size no longer fits all | 2015 | 2 | 102 | 62% |
The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer | 2015 | 4 | 31 | 23% |
Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy | 2015 | 1 | 57 | 63% |
The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations | 2012 | 55 | 88 | 59% |
Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms | 2013 | 19 | 69 | 77% |
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features | 2012 | 72 | 75 | 43% |
Ovarian Cancer | 2009 | 192 | 132 | 41% |
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary | 2014 | 5 | 33 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHERYL BROWN OVARIAN CANC OUTCOMES UNIT | 4 | 47% | 0.6% | 7 |
2 | SIR PETER MACCALLUM CANC | 2 | 44% | 0.3% | 4 |
3 | FOOTHILL MED | 2 | 67% | 0.2% | 2 |
4 | OVCARE | 2 | 67% | 0.2% | 2 |
5 | CANC GENOM GENET PROGRAM | 2 | 50% | 0.3% | 3 |
6 | PATHOL ONCOL GYNECOL OBSTET | 2 | 50% | 0.3% | 3 |
7 | TRANSLAT PL GENOM | 2 | 14% | 0.9% | 10 |
8 | GENET PATHOL EVALUAT PROSTATE | 1 | 38% | 0.3% | 3 |
9 | DENMARK GYNECOL CLIN | 1 | 100% | 0.2% | 2 |
10 | PATHOL CENT CLIN IL | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000221835 | OVARIAN CARCINOMAS//CANC MONTREAL//6Q27 |
2 | 0.0000204218 | BORDERLINE OVARIAN TUMOR//ENDOSALPINGIOSIS//BORDERLINE OVARIAN TUMORS |
3 | 0.0000198456 | PRIMARY FALLOPIAN TUBE CARCINOMA//FALLOPIAN TUBE CARCINOMA//OVARIAN DYSPLASIA |
4 | 0.0000118466 | FERTILITY DRUGS//OVARIAN NEOPLASMS//INCESSANT OVULATION |
5 | 0.0000116807 | BRENNER TUMOR//MALIGNANT BRENNER TUMOR//BRENNER TUMOUR |
6 | 0.0000110740 | OREGOVOMAB//AFLIBERCEPT//GI PERFORATION |
7 | 0.0000094460 | INTERVAL DEBULKING SURGERY//SECONDARY CYTOREDUCTIVE SURGERY//ADVANCED OVARIAN CANCER |
8 | 0.0000085574 | OVARIAN SURFACE EPITHELIUM//OVARIAN SURFACE EPITHELIUM OSE//REPROD BIOL PROGRAM |
9 | 0.0000081258 | SCAR ENDOMETRIOSIS//CATAMENIAL PNEUMOTHORAX//CUTANEOUS ENDOMETRIOSIS |
10 | 0.0000077822 | PSAMMOCARCINOMA//PSAMMOMA BODIES//PRIMARY PERITONEAL CARCINOMA |